Erbi Biosystems
- Company typePrivate
- Founded2015
- HeadquartersWoburn, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Erbi Biosystems firmographics
Firmographics- Name
- Erbi Biosystems
- Website
- https://erbi-bio.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Erbi Biosystems industry classification
Industry- Product category
- Bioprocess Instrumentation
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE)
Keywords
Where Erbi Biosystems is headquartered
LocationHeadquarters
- HQ city
- Woburn
- HQ country
- United States
- HQ region
- North America
Markets served
Erbi Biosystems business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Erbi Biosystems product offering
Product offeringCore offering
Erbi Biosystems develops and manufactures the Breez Bioreactor, a small-scale cell culture platform that combines continuous media addition with online sensing for advanced cell therapy applications. The system targets developers of CAR-T therapies, stem cell therapies, and other cell-based treatments that require precise, controlled culture conditions. Founded in 2015 and headquartered in Woburn, United States, the company operates as a transformative microfluidic bioprocess instrumentation provider serving the cell therapy industry.
Product overview
Erbi Biosystems offers a single unified product — the Breez Bioreactor — which is an advanced small-scale cell culture system. The system is designed for cell therapy applications and features continuous media addition and integrated online sensing for real-time monitoring. The company is developing new cell therapy applications leveraging this platform technology.
Differentiator
Problem solved
Functional benefit
Products and services
- Breez Bioreactor A small-scale cell culture system with continuous media addition and online sensing designed for cell therapy applications including CAR-T and stem cell therapy development. Intended for biotech and pharmaceutical researchers and manufacturers developing cell-based therapies.
Companies that use Erbi Biosystems
Customer profileSegments1 record
Ideal customer profiles1 record
Erbi Biosystems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Erbi Biosystems partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights4 records
Erbi Biosystems competitors and assessment
Company assessmentDirect peers
- PBS Biotech: PBS Biotech makes single-use, high-cell-density bioreactors specifically designed for cell therapy and viral vector manufacturing. Directly comparable to Erbi Breez as both serve cell therapy developers needing small-scale, controlled cell culture systems with monitoring capabilities.
- Applikon Biotechnology: Applikon (now part of Getinge) is a specialist bioreactor manufacturer offering my-Control and similar small-scale systems with advanced sensor integration. Direct overlap with the Breez in delivering controlled, monitored cell culture at small scale.
- Finesse Solutions: Finesse Solutions (now part of Thermo Fisher) built smart sensors, controllers, and bioreactor platforms specifically for cell therapy process monitoring. Direct peer to Erbi on the online sensing and process control layer of small-scale cell culture.
Broad incumbents
- Sartorius AG: Sartorius is a leading supplier of bioprocess equipment, including the ambr line of miniature stirred-tank bioreactors used widely in cell line development and process optimization. Overlaps with Erbi's small-scale bioreactor focus for cell therapy, but Sartorius operates across a much broader bioprocess portfolio.
- Cytiva: Cytiva (formerly GE Healthcare Life Sciences) provides the Xuri cell expansion system and other bioreactor/wave platforms used in cell therapy manufacturing. Overlaps with Erbi on cell therapy culture hardware but competes as a much larger full-line bioprocess supplier.
- Eppendorf: Eppendorf offers the DASbox and DASGIP parallel bioreactor systems widely used for small-scale, sensor-rich process development. Comparable to Erbi in miniaturized bioreactor form factors with online monitoring, but serving broader bioprocess customers beyond cell therapy.
- Thermo Fisher Scientific: Thermo Fisher acquired Finesse Solutions (smart bioreactor sensors and control platforms) and sells a range of bioprocess instruments including the HyPerforma GelliArm system for cell therapy. It is a broad incumbent covering cell therapy manufacturing adjacent to Erbi's niche.
- Corning Life Sciences: Corning supplies single-use bioreactors, culture vessels, and cell expansion platforms (e.g., Corning CELLSTACK, closed-system cell culture) used widely in cell therapy workflows. Comparable adjacent infrastructure to Erbi's Breez in cell therapy manufacturing.
- Miltenyi Biotec: Miltenyi offers the Prodigy and other cell processing/instrumentation systems for cell therapy manufacturing. Overlaps with Erbi as a closed-system, process-controlled cell therapy equipment vendor, with a much broader product portfolio spanning cell separation to bioprocessing.
Emerging players
- Cellexus: Cellexus develops single-use bioreactor systems aimed at cell and gene therapy applications. Closely comparable emerging player focusing on small-scale, automated cell culture technology similar to Erbi's Breez platform.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Erbi Biosystems social profiles
Digital presenceErbi Biosystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Erbi Biosystems leadership team
Management profileNumber of profiles
Profiles5 records
Erbi Biosystems funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Erbi Biosystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Erbi Biosystems
What does Erbi Biosystems do?
Erbi Biosystems develops and manufactures the Breez Bioreactor, a small-scale cell culture platform that combines continuous media addition with online sensing for advanced cell therapy applications. The system targets developers of CAR-T therapies, stem cell therapies, and other cell-based treatments that require precise, controlled culture conditions. Founded in 2015 and headquartered in Woburn, United States, the company operates as a transformative microfluidic bioprocess instrumentation provider serving the cell therapy industry.
Is Erbi Biosystems a public or private company?
Erbi Biosystems is a private company. It is classified as venture growth investor backed and is currently operating.
When was Erbi Biosystems founded?
Erbi Biosystems was founded in 2015. It employs 11 to 50 people.
Where is Erbi Biosystems based?
Erbi Biosystems is headquartered in Woburn, United States, in the North America region.
Who are Erbi Biosystems's main competitors?
Direct peers on record are PBS Biotech, Applikon Biotechnology and Finesse Solutions. Broad incumbents are Sartorius AG, Cytiva, Eppendorf, Thermo Fisher Scientific, Corning Life Sciences and Miltenyi Biotec. Cellexus is listed as an emerging player.
Does Erbi Biosystems have an API?
No public API is recorded for Erbi Biosystems.
What industry is Erbi Biosystems in?
Erbi Biosystems's product category is Bioprocess Instrumentation. Its primary akta.pro industry code is HLAAAJAE, Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES). Its NAICS code is 541714 and its SIC code is 3826.